ENOPARİN 10000 ANTİ-XA IU/1 ML

ENOPARİN 10000 ANTİ-XA IU/1 ML
Product Description

ENOPARİN 10000 ANTİ-XA IU/1 ML 

Polifarma

  • TR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
Primary activities
Animal Health
Finished Formulation products Distributor/Buyer
Laboratory, Analytical, Biotechnology Equipment
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution
Specifications

Polifarma

  • TR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
Primary activities
Animal Health
Finished Formulation products Distributor/Buyer
Laboratory, Analytical, Biotechnology Equipment
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Transport/Logistics/Distribution

More Products from Polifarma (54)

Polifarma resources (2)

Frequently Viewed Together

  • Product Remsima

    The world's 1st mAb biosimilar • Ingredient: Infliximab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Relieves disease progression by inducing a neutralizing response to tumor necrosis factor(TNF-α), the cause of autoimmune disease • Approval status: 100 countri...
  • Product Romiplostim Biosimilar Candidate

    Due to the complex nature of the product, Paras Biopharmaceuticals has been intensively working on this complex drug (Nplate™) for over 6 years and has progressively achieved success. The company plans to mature good value within its Romiplostim asset (Biosimilar) and would like to highlight the following...
  • Product Custom Protein Synthesis

    We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
  • Product UV Light Blocking Tyvek Equipment Covers

    UV Light Blocking Tyvek Equipment Covers are designed to keep cleaned pharmaceutical equipment and supplies clean and protected from external sources of contamination while also providing in-process protection to light sensitive biotech products.
  • Product HANDAYUAN (Adalimumab Injection)

    Our first product indicated for the treatment of autoimmune diseases. HANDAYUAN (adalimumab injection) was approved by the NMPA in December 2020. It is indicated for rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, uveitis, polyarticular juvenile idiopathic arthritis,  pediatric plaque ...
  • Product Ready-to Use CHO cell lines

    UGA Biopharma GmbH offers to their clients so called Ready-to-use Biosimilar Cell Lines. This are in-house developed CHO cell lines stably expressing different biosimilar molecules, that are instantly available for in-licensing. The client profits, because the cell lines are directly available, and develop...
  • Product Biotechnology Services

    Midas Pharma offers a wide range of pharmaceutical services which include biotechnology services. It offers:  • development of biosimilars and proprietary biologicals (starting from gene sequence) • cGMP production (microbial and mammalian cells) • related bioanalytics (from protein biochemical meth...
  • Product Biosimilars Portfolio

    • Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
  • Product RARE DISEASES & ORPHAN DRUGS

    Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products.  USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets.  Many products are made in USA products in FDA approved facilities.
  • Product Biopharmaceutical Characterisation and Testing Services

    Characterization and testing of biopharmaceuticals: Using our expert's insight into a biologic's structure, physicochemical properties, potency, and impurity profile, we help you meet your development milestones.

    A range of expertise is available, including assessment of structure...
  • Product Mipeginterferon alfa-2b

    Pegylated human interferon alfa-2b

    Trade name: PEGBING

    Technology
    Recombinant gene technology, expressed by Yeast

    Amino acid
    165 amino acids

    Molecular weight
    Approximately 59 kD

    Indications
    Chronic hepatitis B & C

    ...
  • Product Humodar C25 100R

    PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar c25 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-...
  • Product Kemwell Biopharma

    SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufa...
  • Product Basalin®(insulin glargine injection)

    Basalin® is an insulin glargine injection developed and produced independently by Gan & Lee Pharmaceuticals. It was launched in China in 2005 and has been approved in almost 20 countries globally. As a long-acting biosimilar insulin, Basalin® is able to stablely control human blood sugar within 24...
  • Product Rituximab

    Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma
  • Product Pharmaceutical and Biological Products Contract Development and Manufact...

    Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, dev...
  • Product Biosimilars

    Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line. Your benefit: Cost and time-savings, while bringing your product to the market. https://excellgene.com/offerings/biosimilars/
  • Product INJECTABLES

    Requiring injectables.EU-GMP is a must.
    EU dossier is a must.
    Licensing and supply model or distributorship.
  • Product Eylea biosimilar vial & PFS

    1.Completion of global clinical trials phase Ⅲ 
    2. Completion of pre-submission meetings with advanced regulatory authorities
    3. Available in Vial and PFS
  • Product Epokine Inj. (rh-EPO)

    Anemia of hemodialysis patients with end-stage renal disease
  • Product Leuprolide 3-Month Implant

    The active ingredient leuprorelin, like goserelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malign...
  • Product Interview by Newsweek, time to talk

    Interviewee:Dr. Steve J.P. Hsu (President of Genovior Biotech)
  • Product Pipeline

    Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
    We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.
  • Product Method Development

    We are specialist in the method development of analytical methods for analysis of API, Final Drug Products or low level impurities. Usually followed by full validation in accordance to ICH guidelines.
  • Product Feronsure

    Interferon alpha 2a 3 MIU/0.5 ml
  • Product Biologics

    End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle

    Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations


    Integrated and flexible drug sub...
  • Product Sterile Grade at ISO Class 5 facility

    Kikkoman can offer "sterile grade” products, purified through a super purification process at our ISO Class 5 facility, approved by the Japanese Authority. 
  • Product Technology Transfer-Biosimilars

    "If you're interested in Tech Transfer projects, our team is well-prepared to assist you with Biosimilar products such as Insulin or Monoclonal Antibodies. We have a network of over 10,000 partners who are willing to explore these opportunities. Please don't hesitate to reach out for more information on th...
  • Product Recombinant human erythropoietin injection (cho cell)

    Shandong kexing bioproducts offers a wide range of products which includes recombinant human erythropoietin injection (cho cell). It is colorless and transparent liquid with ph6.9±0.5. Packaging: pre-filled syringe or vial. Storage: stored at 2-8?. Contact us for more information.

  • Product RinGlar®

    Insulin glargine. 

    Dosage form: solution for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

    ·         Long-acting basal insulin
    ·         Maintains normal physi...
  • Product Biologic drug substance CDMO services

    From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
  • Product Walk in Cooling Cabinet.

    The Walk-In Cooling Cabinets / cold rooms are designed according to ICH guidelines, WHO, MCA and USFDA requirements to maintain uniform conditions. They are superior in airflow distribution, temperature control technology, cabinet construction and are manufactured as per cGMP regulations.
    Biggest Walk...
  • Product Monomaterial Packaging Specialist

    Pharma and Biotech toploading and sideloading cartoning systems from the monomaterial specialistDividella from Switzerland provides pharma and biotech packaging systems for the secondary packaging of parenterals. Dividella's patented top-loading and recently also side-loading cartoners package syringes, vi...
  • Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

    After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

  • Product Biomedtracker

    Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the marke...
  • Product Anakinra Biosimilar Candidate

    Paras Biopharmaceuticals has been intensively working on a Anakinra / IL1-RA biosimilar known as Kineret™) and has progressively achieved success. The company plans to mature good value within its Anakrina / IL1-RA asset and would like to highlight the following points / highlights to gauge your level of ...
  • Product Cell line development services

    Cell line development services, including molecular cloning, CHO cell line development and lead clone selection, bioprocess optimization, DSP and analytical characterization of the target molecule.



  • Product Biosimilars, and High Value Molecules

    Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules.  We are looking for reputable global partners who want to expand their product line and in-license for their territory.
  • Product Remsima SC

    The 1st subcutaneous formulation of infliximab • Ingredient: Infliximab  • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Alleviate disease progression by inducing a neutralizing reaction to TNF-α, the cause of autoimmune disease • Approval status: 49 countries in...
  • Product Herzuma

    • Ingredient: Trastuzumab • Indication: Breast cancer, stomach cancer • Mode of mechanism: Inhibits tumor cell proliferation and growth by binding to a specific antigen (HER2) that occurs specifically and excessively on the surface of tumor cells  • Approval status: 80 countries including US, Euro...
  • Product HANLIKANG (Rituximab Injection)

    HANLIKANG (rituximab injection) is the company's first proprietary product. It is the first-ever China-manufactured biosimilar approved by the NMPA in accordance with the Technical Guideline for the Development and Evaluation of Biosimilars (Tentative) issued in 2015. As of now, HANLIKANG has bee...
  • Product HANBEITAI (Bevacizumab Injection)

    HANBEITAI (generic name: bevacizumab), the fourth product independently developed by Henlius, received marketing approval from the National Medical Products Administration (NMPA) in November 2021, and its commercialization in Chinese mainland is handled by the company's in-house team. As of now, HANBEI...
  • Product Biologic Quality Control and Release Testing

    We deliver responsive QC analysis for complex biologic products from our cGMP laboratories. Our scientists develop and validate methods or perform technology transfer of a sponsor's method for a wide range of analytical methods required for batch release testing. We also routinely carry out testing to Phar...
  • Product Humodar B 100R

    PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar b 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-7 ...
  • Product Biosimilars Testing Services

    Testing services for biosimilars: Our biosimilar analytical comparability programs provide highly relevant data for early stage characterisation and later stage comparison. These programs evaluate and compare all pertinent features of the biosimilar product and are based on the ICH Q6B. Programs encompa...
  • Product Rasburicase Biosimilar candidate

    Paras Biopharmaceuticals has been intensively working on a Romiplostim biosimilar known as Elitek™ / Fasturtec™) and has progressively achieved success. The company plans to mature good value within its Rasburicase asset and would like to highlight the following points / highlights to gauge your level of ...
  • Product Comparability Studies for Biopharmaceuticals

    We design bespoke analytical programmes that ensure that the relevant quality attributes for your drug substance or product are evaluated to support your manufacturing process changes. We select analytics referenced by the ICH Q6B to examine the product's structural features (primary, secondary and&nb...
  • Product Elizaria® (eculizumab)

    Paroxysmal nocturnal hemoglobinuria + atypical hemolytic uremic syndrome

  • Product CORTİPOL 250 Mg I.M./ I.V. POWDER AND SOLVENT FOR PREPARING INJECTION S...

    Active Ingredient:  Methyl Prednisolone Sodium Succinate
    Therapeutic Area: ANTIRHEUMATIC